IL153254A0 - Indole derivatives useful for the treatment of cns disorders - Google Patents

Indole derivatives useful for the treatment of cns disorders

Info

Publication number
IL153254A0
IL153254A0 IL15325401A IL15325401A IL153254A0 IL 153254 A0 IL153254 A0 IL 153254A0 IL 15325401 A IL15325401 A IL 15325401A IL 15325401 A IL15325401 A IL 15325401A IL 153254 A0 IL153254 A0 IL 153254A0
Authority
IL
Israel
Prior art keywords
treatment
cns disorders
indole derivatives
derivatives useful
useful
Prior art date
Application number
IL15325401A
Other languages
English (en)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of IL153254A0 publication Critical patent/IL153254A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL15325401A 2000-06-29 2001-06-13 Indole derivatives useful for the treatment of cns disorders IL153254A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001018 2000-06-29
PCT/DK2001/000407 WO2002000645A1 (en) 2000-06-29 2001-06-13 Indole derivatives useful for the treatment of cns disorders

Publications (1)

Publication Number Publication Date
IL153254A0 true IL153254A0 (en) 2003-07-06

Family

ID=8159589

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15325401A IL153254A0 (en) 2000-06-29 2001-06-13 Indole derivatives useful for the treatment of cns disorders

Country Status (23)

Country Link
US (1) US20030232822A1 (no)
EP (1) EP1299380B1 (no)
JP (1) JP2004501912A (no)
KR (1) KR20030011365A (no)
CN (1) CN1439004A (no)
AR (1) AR028736A1 (no)
AT (1) ATE268765T1 (no)
AU (1) AU2001273882A1 (no)
BG (1) BG107471A (no)
BR (1) BR0112286A (no)
CA (1) CA2414115A1 (no)
CZ (1) CZ20024192A3 (no)
DE (1) DE60103761D1 (no)
EA (1) EA200300084A1 (no)
HU (1) HUP0300786A2 (no)
IL (1) IL153254A0 (no)
IS (1) IS6642A (no)
MX (1) MXPA02012506A (no)
NO (1) NO20026029L (no)
PL (1) PL358966A1 (no)
SK (1) SK1092003A3 (no)
WO (1) WO2002000645A1 (no)
ZA (1) ZA200209886B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117577D0 (en) * 2001-02-16 2001-09-12 Aventis Pharm Prod Inc Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D receptor ligands
AU2003257407A1 (en) * 2002-08-29 2004-03-19 H. Lundbeck A/S S-(+)-3-{1-(2-(2,3-dihydro-1h-indol-3-yl)ethyl)-3,6-dihydro-2h-pyridin-4-yl}-6-chloro-1h-indole and acid addition salts thereof
DE102004027358A1 (de) 2004-06-04 2005-12-29 Abbott Gmbh & Co. Kg Pyrimidinverbindungen und ihre Verwendung
AU2007281591A1 (en) 2006-07-31 2008-02-07 Janssen Pharmaceutica, N.V. Urotensin II receptor antagonists
SE531698C2 (sv) 2007-07-12 2009-07-07 Respiratorius Ab Nya bronkdilaterande a,b-omättade amider
FR2953839A1 (fr) * 2009-12-14 2011-06-17 Sanofi Aventis Nouveaux derives d'(heterocycle-piperidine condensee)-(piperazinyl)-1alcanone ou d'(heterocycle-pyrrolidine condensee)-(piperazinyl)-1alcanone et leur utilisation comme inhibiteurs de p75

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL310443A1 (en) * 1993-03-01 1995-12-11 Merck Sharp & Dohme Derivatives of pyrolo-pyridine
ZA9711376B (en) * 1996-12-20 1998-07-21 Lundbeck & Co As H Indole or dihydroindole derivatives

Also Published As

Publication number Publication date
MXPA02012506A (es) 2003-04-25
AR028736A1 (es) 2003-05-21
CZ20024192A3 (cs) 2003-04-16
BG107471A (en) 2003-10-31
IS6642A (is) 2002-11-29
SK1092003A3 (en) 2003-05-02
US20030232822A1 (en) 2003-12-18
NO20026029D0 (no) 2002-12-16
CA2414115A1 (en) 2002-01-03
PL358966A1 (en) 2004-08-23
EA200300084A1 (ru) 2003-06-26
WO2002000645A1 (en) 2002-01-03
EP1299380B1 (en) 2004-06-09
ZA200209886B (en) 2003-12-05
EP1299380A1 (en) 2003-04-09
DE60103761D1 (de) 2004-07-15
JP2004501912A (ja) 2004-01-22
AU2001273882A1 (en) 2002-01-08
ATE268765T1 (de) 2004-06-15
NO20026029L (no) 2002-12-16
KR20030011365A (ko) 2003-02-07
BR0112286A (pt) 2003-05-13
CN1439004A (zh) 2003-08-27
HUP0300786A2 (hu) 2003-07-28

Similar Documents

Publication Publication Date Title
AU8187701A (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
IL145301A0 (en) 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders
AU2002215047A1 (en) Isoquinoline derivatives useful in the treatment of cns disorders
AU7388101A (en) Indole derivatives useful for the treatment of cns disorders
HRP20030052A2 (en) 4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders
IL153605A0 (en) Indole derivatives useful for the treatment of cns disorders
IL153254A0 (en) Indole derivatives useful for the treatment of cns disorders
HK1039333A1 (en) 3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders
AU8339301A (en) Compounds for the treatment of addictive disorders
SI1468686T1 (sl) S-metil-dihidro-ziprazidon za zdravljenje psihiatricnih motenj
NO20026028D0 (no) Indolderivater nyttige for behandlingen av CNS-forstyrrelser
HU9902737D0 (en) The use of aryl-cyclohexylamine derivatives against cns disorders
IL153351A0 (en) Indole derivatives useful for the treatment of cns disorders
IL153234A0 (en) Indole derivatives useful for the treatment of cns disorders
SI1294710T1 (en) Indole derivatives useful for the treatment of cns disorders
SI1305307T1 (en) Indole derivatives useful for the treatment of cns disorders
AU6007900A (en) Azetidine carboxamide derivatives for the treatment of cns disorders
SI1309586T1 (sl) Derivati 4-,5-,6- in 7-indola uporabni za zdravljenje motenj cns